An MRI-defined measure of cerebral lesion severity to assess therapeutic effects in multiple sclerosis
Crossref DOI link: https://doi.org/10.1007/s00415-015-8009-8
Published Online: 2016-01-11
Published Print: 2016-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kim, Gloria
Tauhid, Shahamat
Dupuy, Sheena L.
Tummala, Subhash
Khalid, Fariha
Healy, Brian C.
Bakshi, Rohit http://orcid.org/0000-0001-8601-5534
Funding for this research was provided by:
Teva Neuroscience
License valid from 2016-01-11